Clinical Trial Update: Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating psilocybin for treatment-resistant major depression in veterans is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Major Depression | Phase 3 | Status: NOT_YET_RECRUITING